Zivo Bioscience- Warrants (29/04/2026) Profit Margin

Zivo Bioscience- Warrants (29/04/2026) posts a profit margin of -8388.36% as of June 2026. That compares with -5558.26% in the prior-year period — down 50.9% year over year. That is below the Consumer Discretionary sector average of 10.14%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Zivo Bioscience- Warrants (29/04/2026)'s profit margin was -5558.26%. The latest reading is -8388.36% — a 50.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Consumer Discretionary stocks, a profit margin near 10.14% is typical. Zivo Bioscience- Warrants (29/04/2026)'s -8388.36% is lower that level. That is roughly 82831.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Zivo Bioscience- Warrants (29/04/2026)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -8388.36% as of June 2026; use YoY and peer views to separate noise from signal.

Context for ZIVOW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 10.14%), and (3) consistency with growth and profitability. This page covers the first two; Zivo Bioscience- Warrants (29/04/2026)'s other metric pages and overview cover the third.